Skip to Main Content

Paper Details

Prognostic biomarkers for survival in mucosal melanoma.
Pigment Cell Melanoma Res
0
2023
CM, KRAS, KRAS mutation, KRAS mutations, MM, Mucosal melanoma, NRAS, Patients, RAS mutations, amelanotic, amelanotic MM, cutaneous melanoma, melanoma, mucosal melanoma, patients
Author NameAffiliation
Vivek NaranbhaiMassachusetts General Hospital, Harvard Medical School
Vivek NaranbhaiMassachusetts General Hospital Cancer Center
Vivek NaranbhaiCenter for the AIDS Programme of Research in South Africa
Vivek NaranbhaiDana-Farber Cancer Institute
Mai P HoangMassachusetts General Hospital, Harvard Medical School
Jochen K LennerzCenter for Integrated Diagnostics, Massachusetts General Hospital and Harvard Medical School
Anthony J IafrateMassachusetts General Hospital, Harvard Medical School
  • 1 - 7

Datasets

Release 1.2